Literature DB >> 2845661

Primary structure and translation of a defective interfering RNA of murine coronavirus.

S Makino1, C K Shieh, L H Soe, S C Baker, M M Lai.   

Abstract

An intracellular defective-interfering (DI) RNA, DIssE, of mouse hepatitis virus (MHV) obtained after serial high multiplicity passage of the virus was cloned and sequenced. DIssE RNA is composed of three noncontiguous genomic regions, representing the first 864 nucleotides of the 5' end, an internal 748 nucleotides of the polymerase gene, and 601 nucleotides from the 3' end of the parental MHV genome. The DIssE sequence contains one large continuous open reading frame. Two protein products from this open reading frame were identified both by in vitro translation and in DI-infected cells. Sequence comparison of DIssE and the corresponding parts of the parental virus genome revealed that DIssE had three base substitutions within the leader sequence and also a deletion of nine nucleotides located at the junction of the leader and the remaining genomic sequence. The 5' end of DIssE RNA was heterogeneous with respect to the number of UCUAA repeats within the leader sequence. The parental MHV genomic RNA appears to have extensive and stable secondary structures at the regions where DI RNA rearrangements occurred. These data suggest that MHV DI RNA may have been generated as a result of the discontinuous and nonprocessive manner of MHV RNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845661      PMCID: PMC7131284          DOI: 10.1016/0042-6822(88)90526-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  36 in total

1.  Phosphoproteins of murine hepatitis viruses.

Authors:  S A Stohlman; M M Lai
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Genomic RNA of the murine coronavirus JHM.

Authors:  H Wege; A Müller; V ter Meulen
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

3.  Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase.

Authors:  L H Soe; C K Shieh; S C Baker; M F Chang; M M Lai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus.

Authors:  S Makino; N Fujioka; K Fujiwara
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

6.  Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length.

Authors:  M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

7.  High-frequency RNA recombination of murine coronaviruses.

Authors:  S Makino; J G Keck; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

8.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus.

Authors:  M M Lai; R S Baric; P R Brayton; S A Stohlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain.

Authors:  S Makino; F Taguchi; N Hirano; K Fujiwara
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

10.  The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription.

Authors:  C K Shieh; L H Soe; S Makino; M F Chang; S A Stohlman; M M Lai
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

View more
  57 in total

1.  RNA recombination in brome mosaic virus: effects of strand-specific stem-loop inserts.

Authors:  R C L Olsthoorn; A Bruyere; A Dzianott; J J Bujarski
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Isolation and characterization of an arterivirus defective interfering RNA genome.

Authors:  R Molenkamp; B C Rozier; S Greve; W J Spaan; E J Snijder
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  cis Requirement for N-specific protein sequence in bovine coronavirus defective interfering RNA replication.

Authors:  R Y Chang; D A Brian
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Replication of murine coronavirus defective interfering RNA from negative-strand transcripts.

Authors:  M Joo; S Banerjee; S Makino
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  High-frequency leader sequence switching during coronavirus defective interfering RNA replication.

Authors:  S Makino; M M Lai
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Secondary structural elements within the 3' untranslated region of mouse hepatitis virus strain JHM genomic RNA.

Authors:  Q Liu; R F Johnson; J L Leibowitz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis.

Authors:  L Aurisicchio; P Delmastro; V Salucci; O G Paz; P Rovere; G Ciliberto; N La Monica; F Palombo
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription.

Authors:  Y J Lin; C L Liao; M M Lai
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription.

Authors:  C L Liao; M M Lai
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication.

Authors:  Y J Lin; M M Lai
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.